Black cohosh extracts in women with menopausal symptoms: an updated pairwise meta-analysis
- PMID: 37192826
- DOI: 10.1097/GME.0000000000002196
Black cohosh extracts in women with menopausal symptoms: an updated pairwise meta-analysis
Abstract
Objective: Menopausal symptoms are common in midlife women and have broad impacts on their daily functioning and quality of life. Black cohosh extracts have been widely used to relieve menopausal symptoms. However, the comparative benefits of different combined black cohosh regimens remain inconclusive. The aim of the current updated meta-analysis is to address the comparative efficacies of different black cohosh regimens in improving menopausal symptoms.
Methods: Random-effect model pairwise meta-analysis of randomized controlled trials was conducted to investigate the treatment effect on menopausal symptoms by the black cohosh extract both alone or combined with other related active ingredients. The outcomes studied were changes in menopausal symptoms after treatment with black cohosh extracts in menopausal women.
Results: Twenty-two articles including information on 2,310 menopausal women were included in the analyses. Black cohosh extracts were associated with significant improvements in overall menopausal symptoms (Hedges' g = 0.575, 95% CI = 0.283 to 0.867, P < 0.001), as well as in hot flashes (Hedges' g = 0.315, 95% CIs = 0.107 to 0.524, P = 0.003), and somatic symptoms (Hedges' g = 0.418, 95% CI = 0.165 to 0.670, P = 0.001), compared with placebo. However, black cohosh did not significantly improve anxiety (Hedges' g = 0.194, 95% CI = -0.296 to 0.684, P = 0.438) or depressive symptoms (Hedges' g = 0.406, 95% CI = -0.121 to 0.932, P = 0.131). The dropout rate for black cohosh products was similar to that for placebo (odds ratio = 0.911, 95% CI = 0.660 to 1.256, P = 0.568).
Conclusions: This study provides updated evidence regarding the potentially beneficial effects of black cohosh extracts for relieving menopausal symptoms in menopausal women.
Copyright © 2023 by The North American Menopause Society.
Conflict of interest statement
Financial disclosure/conflicts of interest: Y.J.M. has received speaker fees from Suntory Wellness, Pfizer, Mochida, Eli Lilly, Morinaga Milk, and Cimic. The other authors have nothing to disclose.
Similar articles
-
Black cohosh (Cimicifuga spp.) for menopausal symptoms.Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD007244. doi: 10.1002/14651858.CD007244.pub2. Cochrane Database Syst Rev. 2012. PMID: 22972105 Free PMC article. Review.
-
Efficacy of black cohosh (Cimicifuga racemosa) medicines for treatment of menopausal symptoms - comments on major statements of the Cochrane Collaboration report 2012 "black cohosh (Cimicifuga spp.) for menopausal symptoms (review)".Gynecol Endocrinol. 2013 Dec;29(12):1022-5. doi: 10.3109/09513590.2013.831836. Epub 2013 Sep 2. Gynecol Endocrinol. 2013. PMID: 23992293
-
Cimicifuga racemosa extract for relieving menopausal symptoms: a randomized controlled trial.Climacteric. 2015 Feb;18(1):79-85. doi: 10.3109/13697137.2014.933410. Epub 2014 Sep 22. Climacteric. 2015. PMID: 24941138 Clinical Trial.
-
Black cohosh efficacy and safety for menopausal symptoms. The Spanish Menopause Society statement.Gynecol Endocrinol. 2022 May;38(5):379-384. doi: 10.1080/09513590.2022.2056591. Epub 2022 Apr 11. Gynecol Endocrinol. 2022. PMID: 35403534
-
Black cohosh: an alternative therapy for menopause?Nutr Clin Care. 2002 Nov-Dec;5(6):283-9. doi: 10.1046/j.1523-5408.2002.05603.x. Nutr Clin Care. 2002. PMID: 12557811 Review.
Cited by
-
Plants of the USA: recordings on native North American useful species by Alexander von Humboldt.J Ethnobiol Ethnomed. 2024 Sep 17;20(1):87. doi: 10.1186/s13002-024-00727-3. J Ethnobiol Ethnomed. 2024. PMID: 39289725 Free PMC article.
-
Midlife Women's Menopausal Transition Symptom Experience and Access to Medical and Integrative Health Care: Informing the Development of MENOGAP.Glob Adv Integr Med Health. 2024 Jul 30;13:27536130241268355. doi: 10.1177/27536130241268355. eCollection 2024 Jan-Dec. Glob Adv Integr Med Health. 2024. PMID: 39092447 Free PMC article.
-
Traditional uses, phytochemistry, pharmacology, quality control and clinical studies of Cimicifugae Rhizoma: a comprehensive review.Chin Med. 2024 May 7;19(1):66. doi: 10.1186/s13020-024-00937-7. Chin Med. 2024. PMID: 38715120 Free PMC article. Review.
References
-
- Nelson HD. Menopause. Lancet 2008;371:760–770. doi: 10.1016/S0140-6736(08)60346-3 - DOI
-
- Avis NE, Crawford SL, Greendale G, et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med 2015;175:531–539. doi: 10.1001/jamainternmed.2014.8063 - DOI
-
- Davis SR, Lambrinoudaki I, Lumsden M, et al. Menopause. Nat Rev Dis Primers 2015;1:15004. doi: 10.1038/nrdp.2015.4 - DOI
-
- Shahnazi M, Nahaee J, Mohammad-Alizadeh-Charandabi S, Bayatipayan S. Effect of black cohosh (cimicifuga racemosa) on vasomotor symptoms in postmenopausal women: a randomized clinical trial. J Caring Sci 2013;2:105–113. doi: 10.5681/jcs.2013.013 - DOI
-
- Oktem M, Eroglu D, Karahan HB, Taskintuna N, Kuscu E, Zeyneloglu HB. Black cohosh and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized trial. Adv Ther 2007;24:448–461. doi: 10.1007/BF02849914 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources